65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79726D0158
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 1% complete
IDV ceiling
$11,119,000.00
Award type
Multiple award
Who can order
All agencies
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs issued a Federal Supply Schedule contract to Rare Disease Therapeutics, Inc. on September 29, 2026, under VA Schedule 65 I B (Drugs, Pharmaceuticals, & Hematology Related Products) with a ceiling of $11.119 million and an ultimate completion date of September 28, 2031.

Rare Disease Therapeutics, Inc. is a woman-owned small business headquartered in Franklin, Tennessee. The company specializes in specialty pharmaceutical products, with primary focus on orphan drugs and medical countermeasures for federal healthcare agencies. The contract covers the full scope of Schedule 65 I B and serves as a multi-agency catalog vehicle; federal agencies place orders against the approved price list rather than conducting new competitions.

The contractor's historical ordering activity centers on distribution of ANASCORP scorpion antivenom injections and other specialty pharmaceutical products to federal healthcare providers, particularly the Indian Health Service and VA facilities. Prior deliveries have been structured as firm fixed-price task orders and BPA calls to clinics and service units across Arizona and other locations. The company's existing federal relationships include prior BPAs with the VA National Acquisition Center and the Indian Health Service, supporting similar pharmaceutical product distribution to tribal health facilities and specialized medical centers.

Place of performance is nationwide, consistent with GSA Schedule scope. The contractor is registered in SAM.gov and operates as a for-profit small business without additional socioeconomic set-asides under this vehicle.

Quick answers

Who was awarded contract 36F79726D0158?

36F79726D0158 was awarded to Rare Disease Therapeutics, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 29, 2026.

How much is contract 36F79726D0158 worth?

36F79726D0158's own ceiling is $11,119,000.

Who can order from contract 36F79726D0158?

36F79726D0158 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79726D0158 part of a contract vehicle?

Yes. 36F79726D0158 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79726D0158 competed?

The extent of competition for 36F79726D0158 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV